Quai.MD
Quai.MD develops a unique AI-based platform to help doctors diagnose patients accurately in real time
Quai.MD develops a unique AI-based platform to help doctors diagnose patients accurately in real time
Published Oct 15, 2026
| Starting Price | Not publicly disclosed (demo-led) | Not publicly disclosed (enterprise; trust center available) | Not publicly disclosed for enterprise; bulk pricing referenced in media |
| Primary focus | ED-focused workflow guidance and documentation embedded in the EHR (vendor messaging) | Ambient conversation capture and note generation with an emphasis on security artifacts | Scribe automation and "copilot" workflows; broader deployments reported in press |
| Noted strengths | Vendor-reported pathway and workup guidance combined with documentation generation; ED-focused messaging | Public trust artifacts available (SOC 2 Type II reported) and broader enterprise visibility | Reported enterprise deployments and media coverage; positions as a copilot for documentation workflows |
| Noted limitations | Public security attestations and independent third-party product reviews are limited in accessible sources | Primarily scribe/conversation-centered; may not provide embedded pathway guidance | Less emphasis on embedded clinical pathway decision support in public materials |
—
According to vendor messaging, Quai.MD provides both documentation automation and differential/workup pathway support within the EHR. Competitors that focus on scribing and ambient documentation may have broader public footprints and clearer public security documentation; scribe-first tools can sometimes be faster to pilot depending on the integration approach and governance requirements.
Where competitors may excel:
Sources: